ArticleVirologica Sinica2026

HVT-based multiepitope vaccine administered subcutaneously or in ovo boosts protection of inactivated H9N2 vaccine against heterologous virus.

Zimin Xie et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.